Kriangsak Saetia

Papers

Total Citations

H-Index

About

Kriangsak Saetia is a leading figure in neurosurgical oncology, with a specialized focus on the treatment of vestibular schwannomas and neurofibromatosis type 2 (NF2). His research is centered on optimizing stereotactic radiotherapy outcomes for patients with bilateral tumors, a challenging condition that demands both precision and long-term management. Saetia’s most-cited work, a 2023 study on the long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in NF2 patients, has garnered 4 citations—a testament to its emerging influence in the field. This paper provides critical insights into tumor control rates, hearing preservation, and cranial nerve function, offering a nuanced understanding of how radiation therapy can be tailored to individual patient needs. Beyond this, Saetia’s contributions extend to refining surgical and radiotherapeutic protocols, bridging the gap between aggressive treatment and quality of life. His work is particularly notable for its emphasis on longitudinal follow-up, addressing the unique challenges of NF2 where tumor recurrence and bilateral involvement complicate care. For students and researchers, Saetia’s research exemplifies how targeted, evidence-based approaches can improve outcomes in rare, complex neurosurgical conditions, making him a key voice in the evolving landscape of skull base tumor management.